Skip to content

Clinical trials

Recruiting Overweight trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Recruiting Country / region: Italy Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20245
202510
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Novo Nordisk A/S3
Hoffmann-La Roche2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
Amgen1
AstraZeneca1
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1
Bambino Gesù Hospital and Research Institute1
Fondazione Don Carlo Gnocchi ETS1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight27
Obesity25
Diabetes Mellitus, Type 23
Diabetes Mellitus2
Weight Loss2
Alzheimer Disease1
Atherosclerosis1
Binge-Eating Disorder1
Body Weight1
Bone Diseases, Metabolic1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.